Tech vendors flock to DIA to show off new software

With the clinical trial community gathering over the past week in San Diego for DIA 2014, eClinical technology providers posted a flurry of press releases detailing new and updated offerings. Parexel ($PRXL), PatientsLikeMe and BBK Worldwide were among the companies to show off their wares at the meeting.

PatientsLikeMe has continued to expand beyond its original function as a patient community by adding more clinical research services. The first of its three new offerings is designed to give patients a say in the design and running of clinical trials by providing biopharma companies with tools for gathering feedback. PatientsLikeMe introduced the tool after a survey of its community showed that 20% of people who participated in trials are dissatisfied by the experience. The company introduced tools for building registries and improving patient-reported evidence, too.

BBK Worldwide also added to the chatter around this year's DIA buzzword: patient-centricity. The Needham, MA-based patient recruitment specialist showed off new apps for Apple ($AAPL) and Android devices to help sites enroll people in studies and reduce dropout rates. My Clinical Study Buddy tries to tackle the issue of patients dropping out of trials by helping them manage the logistics of taking part in a study. The Protocol Pointers Edition version of the app is designed to ease patient recruitment by giving sites tutorials and protocol information.

San Francisco, CA-based endpoint made its interactive response technology product, Pulse, available on a Software-as-a-Service model. The goal is to increase the level of customization available to customers.

PHT selected Dell Venue 11 Pro tablets for its SitePad System, an electronic replacement for paper-based data collection. The Windows 8.1-based products were picked because of their 4G capabilities and Windows operating system, with PHT viewing the package as sufficiently compelling to shell out for 2,000 of the tablets.

Parexel introduced a new version of its ClinPhone randomization and trial supply management service, with the CRO talking up the use of prebuilt modules to speed setup.

- read the PatientsLikeMe release
- here's the BBK release
- check out endpoint's news
- read the PHT release
- and Parexel's news

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.